Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Deacetylasperulosidic acid is a **naturally occurring iridoid glycoside** found in plants such as *Morinda citrifolia* (noni), *Gardenia jasminoides*, and *Galium rivale*[5][6]. It exhibits **antioxidant** activity by upregulating superoxide dismutase (SOD)[5][1][7][8], with evidence of dose-dependent reduction of oxidative markers in animal studies[5]. Deacetylasperulosidic acid also demonstrates **anti-inflammatory** properties by suppressing multiple cytokines and chemokines linked to inflammatory and allergic responses (e.g., TNF-α, IL-4, IL-6, IL-8, IL-1, IL-25, IL-33), reduces histamine secretion, and modulates MAPK/NF-kB signaling[1]. Additionally, it can restore immune balance, activate natural killer cells, and enhance IL-2 production[1][7]. In obesity models, deacetylasperulosidic acid binds peroxisome proliferator-activated receptor alpha (PPARα), decreases mature adipocyte proliferation, and significantly reduces triglyceride and cholesterol levels in animal models[1]. It also shows moderate activity in preventing SARS-CoV-2 spike protein binding to ACE2[1]. Its anticlastogenic effects are demonstrated by suppressing induction of chromosomal aberrations in cell and animal models[8]. The compound is primarily developed and studied as a **bioactive phytochemical** ingredient for research and nutraceutical purposes, especially in antioxidant and immune balance applications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on deacetylasperulosidic acid.